Drug development and adverse reactions

All Items

• A New Pathogenic Variant of the RTEL1 Gene and Dyskeratosis Congenita: A Dermatological View

  Sanaz Amin Guldmann, Anna Byrjalsen, Saher Shaker, Jesper Elberling

  adv00710

• A Rare Case of Widely Disseminated Syphilis

  Agnieszka Slyk, Maria Hedman, Arne Wikström

  adv27983

• Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine

  Fouad Mitri, Ferdinand Toberer, Alexander H. Enk, Martin Hartmann

  adv00596

• Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series

  Valerie Glutsch, Patrick Schummer, Ann-Cathrin Koschker, Matthias Goebeler, Marion Wobser

  adv19672

• Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma

  Mireille M. Hermans, Corstiaan C. Breugem, Renske Schappin, Emma Jonge Poerink, Elodie J. Mendels, Aviël Ragamin, Johannes M.P.J. Breur, Hester R. Langeveld, Martine F. Raphael, Peter C.J. de Laat, Saskia N. de Wildt, André B. Rietman, Suzanne G.M.A. Pasmans, Marlies de Graaf

  adv00788

• Antipruritic Effect of Topical Acetaminophen Gel in Histaminergic and Non-histaminergic Itch Provocation: A Double-blind, Vehicle-controlled Pilot Study

  Leigh A. Nattkemper, Kaining Zhi, Kaeli E. Romero, Serena M. Shah, Teresa Ju, Kayla Fourzali, Rachel Shireen Golpanian, Flor MacQuhae, Yiong Huak Chan, David B. Lebo, Gil Yosipovitch

  adv00640

• Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report

  Han Seul Kim, Ji Eun Kwon, Young Joon Park

  adv9646

• BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study

  Shir Azrielant, Yair Levin, Alon Peled, Liat Samuelov, Eli Sprecher, Mor Pavlovsky

  adv18389

• Blistering Papulosquamous Erythema with Arthralgia: A Quiz

  Yukiho Kurosaki, Yosuke Ishitsuka, Yasuhiro Kato, Noriko Arase, Manabu Fujimoto

  adv00690

• Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature

  Aikaterini Tsiogka, Johann W. Bauer, Aikaterini Patsatsi

  adv00377

• Chilblain-like Lesions after COVID-19 Vaccination: A Case Series

  Roberto Russo, Emanuele Cozzani, Claudia Micalizzi, Aurora Parodi

  adv00711

• Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions

  Marios Koumourtzis, Kyriaki Lampadaki, Maria Dalamaga, Evangelia Papadavid

  adv00730

• Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study

  Heber Rew Bright, Sujith J. Chandy, Renu George

  adv13348

• Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis

  Farnam Barati Sedeh, Thorunn Elísabet Michaelsdóttir, Mattias Arvid Simon Henning, Gregor Borut Ernst Jemec, Kristina Sophie Ibler

  adv00855

• Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis

  Farnam B. Sedeh, Mattias A.S. Henning, Gregor B.E. Jemec, Kristina S. Ibler

  adv00764

• COVID-19 Vaccination-related Complex Regional Pain Syndrome Masquerading as Erythromelalgia: A Case Report

  Kristian L. Lorentzen, Anette Bygum

  adv13400

• Cutaneous Adverse Events to Targeted Therapies and Immuno­therapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres

  Ayelet Ollech, Michal Yalon, Gadi Abebe-Campino, Vered Molho-Pessach, Eve Finklestein, Hodaya Cohen, Aviv Barzilai, Shani Caspi, Shoshana Greenberger

  adv00501

• Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis

  Clara Chelli, Jeffrey Loget, Clélia Vanhaecke, Anne Durlach, Laurence Gagneux-Lemoussu, Clothilde Soriano, Manuelle Viguier

  adv00077

• Dermatological Conditions Inducing Acute and Chronic Pain

  Mathilde Hayoun-Vigouroux, Laurent Misery

  adv00742

• Development of Multiple Cherry Angiomas in a Child after COVID-19 Vaccination

  Majken H. Petersen, Marie Bjørn

  adv00870

• Drug-induced Granulomatous Panniculitis: Polarization of M1/M2 Macrophages

  Naomi Tani, Nanako Yamada, Yuichi Yoshida

  adv18855

• Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature

  Shin-ichi Osada, Takahiko Sato

  adv00468

• Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis

  LiMing Wu, Kamran Ali, YunMi Qiu, MengHua Li, JiaYang Da

  adv00743

• Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

  Martin Kaatz, Peter Mohr, Elisabeth Livingstone, Michael Weichenthal, Alexander Kreuter, Claudia Pföhler, Ulrike Leiter, Jens Ulrich, Jochen Sven Utikal, Ralf Gutzmer, Rudolf Herbst, Dirk Schadendorf

  adv00695

• Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series

  Federica Repetto, Lorenza Burzi, Simone Ribero, Pietro Quaglino, Paolo Dapavo

  adv00780

• Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema

  Emily Y. Kim, Katherine C. Awh, Cecilia A. Larocca

  adv12197

• Fixed Drug Eruption due to Dupilumab

  Ayaka Kaneoka, Natsuko Saito-Sasaki, Yumiko Sakuragi, Yu Sawada

  adv37804

• Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center

  Linda Davidson, Juul M.P.A. van den Reek, Florence van Hunsel, Elke M.G.J. de Jong; Bart Jan Kullberg

  adv00648

• Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

  Dana Shalmon, Efrat Bar-Ilan, Alon Peled, Shamir Geller, Jonathan Bar, Naama Schwartz, Eli Sprecher, Mor Pavlovsky

  adv26663

• Inhibition of Transforming Growth Factor Beta and Immune Checkpoints Induces a Distinctively Distributed, Severe Bullous Pemphigoid

  Soo Hyun Choi, Kyung Bae Chung, Do-Young Kim

  adv00489

• Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa

  Patricia Garbayo-Salmons, Mireia Moreno Martínez-Losa, Vicente Exposito-Serrano, Miquel Ribera, Joan

  adv40145

• Langerhans Cell Histiocytosis Caused by Adalimumab for Crohn’s Disease: A Case Report

  Mariko Kochi, Tetsuya Higuchi

  adv10285

• Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited

  Elisa Ríos-Viñuela, Eduardo Bernia, Tomás Toledo-Pastrana, Celia Requena, Adrián Diago, Carlos Serra-Guillén, Beatriz Llombart, Victor Traves, Eduardo Nagore, Carlos Guillén, Onofre Sanmartin

  adv00429

• Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience

  Tiffany J. Garcia-Saleem, Connor J. Stonesifer, Alexandra E. Khaleel, Larisa J. Geskin

  adv00544

• Minocycline-induced Hyperpigmentation Confined to Lupus Miliaris Disseminatus Faciei

  Masakazu Kakurai, Rie Honda, Hanako Miyahara, Shusaku Ito

  adv18462

• Mucocutaneous Adverse Reactions to COVID-19 Vaccines: Do Excipients Play a Role?

  Leonardo Bianchi, Filippo Biondi, Katharina Hansel, Nicola Murgia, Alessandro D'Arpino, Marta Tramontana, Luca Stingeni

  adv00724

• Mucosal Fixed Drug Eruption with Oral, Conjunctival, Nasal, and Anal Lesions: A Case Report

  Noriko Yoshida, Fumi Miyagawa, Yasuhiro Mitsui, Kohei Ogawa, Takashi Hashimoto, Hideo Asada

  adv18295

• Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects

  Jana D. Albrecht, Nadia Ninosu, Denise Barry, Thomas Albrecht, Marthe-Lisa Schaarschmidt, Sergij Goerdt, Jan P. Nicolay

  adv00722

• Painful Erythematous Plaques on the Hands: A Quiz

  Anna Ochi, Yasuhiro Mitsui, Kohei Ogawa, Hideo Asada

  adv12344

• Pityriasis Lichenoides et Varioliformis Acuta Triggered by Human Papillomavirus Vaccine: A Case Report and Literature Review

  Beata A. Jastrząb, Aleksandra A. Stefaniak, Anita Hryncewicz-Gwóźdź, Piotr Nockowski, Jacek C. Szepietowski

  adv00552

• Primary Cutaneous B-cell Lymphoma Leg-type Related to a Tumour Necrosis Factor Alpha Inhibitor

  Samy Belkaïd, Brigitte Balme, Olivier Harou, Joann Le Borgne de la Villandré, Chloé Wirbel, Stéphane Dalle, Florent Grange

  adv00688

• Propylthiouracil-induced Alopecia Accompanying Hypohidrosis and Onychomadesis

  Nozomi Yanagida, Shunsuke Takahagi, Akio Tanaka, Michihiro Hide

  adv00763

• Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?

  David Pesqué, Blanca Sanchez-Gonzalez, Fernando Gallardo, Sonia Segura, Ramon M. Pujol

  adv00418

• Psoriatic Skin Lesions after Apalutamide Treatment

  Fumi Miyagawa, Nobuya Akioka, Noriko Yoshida, Kohei Ogawa, Hideo Asada

  adv00659

• Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab

  Mingxia Wang, Qi Zheng, Suwei Tang, Fang Shen, Wenchen Jiang

  adv00744

• Real-world Experience of Abrocitinib on Difficult-to-treat Hand Eczema in Chinese Patients

  Yiting Li, Xi Tan, Shu Nie, Xin Tian, Zhouwei Wu

  adv39822

• Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review

  Diva Amiri, Christopher Willy Schwarz, Lise Gether, Lone Skov

  adv00890

• Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases

  Sonja Braasch, Carsten Weishaupt, Eva Spukti, Markus Böhm, Stephan Alexander Braun

  adv00792

• Simultaneous Development of Gianotti-Crosti Syndrome and Erythema Multiforme Following Second Dose of Measles-rubella Vaccine

  Masahiro Oka

  adv00438

• Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

  Tanja Batinac, Nika Hlača, Luka Simetić, Frane Valković, Sandra Peternel, Larisa Prpić-Massari

  adv00650